← Open Payments lookup

BOLANLE OLAYIWOLE: Open Payments

NPI 1780187138 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,285 in 45 payments from 8 companies in 2025. Trend: 2023 $1,886 · 2024 $1,282 · 2025 $2,285

Food & beverage: $2,176Education: $109
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.22$818
Neurocrine BioSciences, Inc.10$340
Janssen Scientific Affairs, LLC2$286
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$262
Janssen Pharmaceuticals, Inc2$236
Luye Pharma (USA) Ltd.2$152
Otsuka America Pharmaceutical, Inc.3$140
Alkermes, Inc.2$52

Products named: AUSTEDO XR, INVEGA SUSTENNA, INGREZZA, CAPLYTA, ERZOFRI EXTENDED-RELEASE, ABILIFY ASIMTUFII, UZEDY, ARISTADA.

Industry payments across TX — which companies pay providers there.